The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...

The news for the chocolate industry is a welcome development, as businesses and scientists grapple with crop shortages.

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a ...

Researchers from the UK and Germany have announced to have developed pigs that are resistant to Classical Swine Fever.

BANDUNG, itb.ac.id - The PINTAR Diagnostics team from the School of Life Sciences and Technology (SLST), Institut Teknologi ...

CRISPR Gene Editing Market To Hit $12.78B By 2033, Kits & Reagents 60.5% Share, Cas9 Drives Innovation. EINPresswire/ -- CRISPR Gene Editing: A Technological Overview CRISPR gene editing has ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Investing.com -- Intellia Therapeutics (NASDAQ:NTLA) stock fell 19% after the market close Wednesday after the U.S. Food and Drug Administration (FDA) placed a clinical hold on the company’s Phase 3 ...

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...